D-1291-2020 Class III Terminated
FDA drug recall D-1291-2020 was initiated by UNICHEM PHARMACEUTICALS USA INC on May 26, 2020 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: potential migration of benzophenone at very low level into the product from container. The recall status is terminated (terminated Jan 8, 2021). Affected quantity: 190,992 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 17, 2020
- Initiation Date
- May 26, 2020
- Termination Date
- Jan 8, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 190,992 bottles
Product description
Clonidine Hydrochloride Tablets, USP 0.1 mg 100-count bottles, Rx only, Manufactured by: Unichem Laboratories LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India Manufactured for : Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816, NDC 29300-135-01
Reason for recall
Failed Impurities/Degradation Specifications: potential migration of benzophenone at very low level into the product from container.
Distribution pattern
Nationwide within the United States
Code information
Lot #: GCLL19034, GCLL19035, GCLL19036, Exp. 4/30/2021; GCLL19044, Exp. 6/30/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1291-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026